Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew A Lane

Showing results (31-40 of 102) with videos related to

Pageof 11
Sort By:
British Journal of Haematology|October 13, 2025
First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trialAnthony S Stein, Andrew A Lane, Kendra L Sweet, et al.
Blood Advances|April 11, 2024
Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survivalShai Shimony, Julia Keating, Christopher J Fay, et al.
Journal of Autoimmunity|September 26, 2017
Monogenic Hashimoto thyroiditis associated with a variant in the thyroglobulin (TG) geneMindy S Lo, Meghan Towne, Grace E VanNoy, et al.
Blood Advances|October 30, 2023
AMPK activation induces immunogenic cell death in AMLJohanna Mondesir, Margherita Ghisi, Laura Poillet, et al.
Blood Advances|January 4, 2018
Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screeningMarlise R Luskin, Marie N Discenza, Sarah Rae Easter, et al.
Leukemia & Lymphoma|February 23, 2024
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerationsNaveen Pemmaraju, Yazan F Madanat, David Rizzieri, et al.
Blood Advances|January 18, 2023
Genomics of PDGFR-rearranged hypereosinophilic syndromeEsther Rheinbay, Meifang Qi, Juliette M Bouyssou, et al.
Leukemia & Lymphoma|December 17, 2025
Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasmNaveen Pemmaraju, Marina Konopleva, Muzaffar Qazilbash, et al.
Blood Neoplasia|June 2, 2025
Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCNNaveen Pemmaraju, Luan Hai Phan, Geoffrey Fell, et al.
Molecular and Cellular Biology|December 2, 2004
Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signaturesMatthew J Walter, John S Park, Steven K M Lau, et al.
Pageof 11

Showing results (31-40 of 102) with videos related to

Sort By:
Pageof 11
British Journal of Haematology|October 13, 2025
First-line tagraxofusp induces durable responses with prolonged survival in adults younger than 50 years with blastic plasmacytoid dendritic cell neoplasm: Post hoc analysis of a phase 2 trialAnthony S Stein, Andrew A Lane, Kendra L Sweet, et al.
Blood Advances|April 11, 2024
Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survivalShai Shimony, Julia Keating, Christopher J Fay, et al.
Journal of Autoimmunity|September 26, 2017
Monogenic Hashimoto thyroiditis associated with a variant in the thyroglobulin (TG) geneMindy S Lo, Meghan Towne, Grace E VanNoy, et al.
Blood Advances|October 30, 2023
AMPK activation induces immunogenic cell death in AMLJohanna Mondesir, Margherita Ghisi, Laura Poillet, et al.
Blood Advances|January 4, 2018
Maternal iAMP21 acute lymphoblastic leukemia detected on prenatal cell-free DNA genetic screeningMarlise R Luskin, Marie N Discenza, Sarah Rae Easter, et al.
Leukemia & Lymphoma|February 23, 2024
Treatment of patients with blastic plasmacytoid dendritic cell neoplasm (BPDCN): focus on the use of tagraxofusp and clinical considerationsNaveen Pemmaraju, Yazan F Madanat, David Rizzieri, et al.
Blood Advances|January 18, 2023
Genomics of PDGFR-rearranged hypereosinophilic syndromeEsther Rheinbay, Meifang Qi, Juliette M Bouyssou, et al.
Leukemia & Lymphoma|December 17, 2025
Durable post-transplant survival after first-line tagraxofusp for blastic plasmacytoid dendritic cell neoplasmNaveen Pemmaraju, Marina Konopleva, Muzaffar Qazilbash, et al.
Blood Neoplasia|June 2, 2025
Prospective clinical trials of venetoclax and hypomethylating agents for relapsed BPDCNNaveen Pemmaraju, Luan Hai Phan, Geoffrey Fell, et al.
Molecular and Cellular Biology|December 2, 2004
Expression profiling of murine acute promyelocytic leukemia cells reveals multiple model-dependent progression signaturesMatthew J Walter, John S Park, Steven K M Lau, et al.
Pageof 11